High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$2.2M
$2,186,180
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
NAMS
S
NewAmsterdam Pharma Co N.V.
LANGE LOUIS G
• Director
Discretionary Sell
2026-03-11
$1,357,230Largex2
|
||||||
| NAMS |
NewAmsterdam Pharma Co N.V.
|
Director
Discretionary Sell
|
2026-03-11 | $1,357,230Largex2 | S | Form 4 |
| NAMS |
NewAmsterdam Pharma Co N.V.
|
Director
Other
|
2026-03-09 | $513,118 | X | Form 4 |
| NAMS |
NewAmsterdam Pharma Co N.V.
|
Director
Discretionary Sell
|
2026-03-06 | $828,950 | S | Form 4 |